The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Longitudinal, prospective cardiovascular and metabolic risk in treatment-naive patients with chronic myeloid leukemia in chronic phase (CML-CP) starting tyrosine kinase inhibitor (TKI) therapy in a real-world setting.
 
Javid J. Moslehi
Consulting or Advisory Role - AstraZeneca/MedImmune; BeiGene; BMS; Deciphera; Mallinckrodt; Myovant Sciences; Novartis; Pfizer; Pharmacyclics; Takeda
 
Mandar A. Aras
Employment - Genentech/Roche (I)
 
Vivian G. Oehler
Consulting or Advisory Role - Ascentage Pharma; Novartis; Pfizer
Research Funding - Pfizer (Inst)
 
James E. Thompson
Research Funding - Bristol-Myers Squibb; Novartis
 
James K. McCloskey
Honoraria - BluPrint Oncology; Bristol-Myers Squibb/Pfizer
Consulting or Advisory Role - Blueprint Medicines; Bristol-Myers Squibb/Pfizer; Novartis
Speakers' Bureau - Amgen; BluePrint Health; Bristol-Myers Squibb/Pfizer; Incyte; Jazz Pharmaceuticals; Stemline Therapeutics; Takeda
 
Michael C. Heinrich
Honoraria - Novartis
Consulting or Advisory Role - Blueprint Medicines; Deciphera; Novartis; Theseus Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Patent on treatment of GIST-licensed to Novartis (Inst)
 
Irene S. DeGutis
Employment - Bristol-Myers Squibb
 
Susan Meredith Fish
Employment - Bristol Myers Squibb
Stock and Other Ownership Interests - Bristol Myers Squibb
 
Michael J. Mauro
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer; Takeda; Terns Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer; Takeda; Terns Pharmaceuticals
Research Funding - Bristol-Myers Squibb; Novartis; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer; Takeda; Terns Pharmaceuticals